4.4 Article

Eating disorder not otherwise specified presentation in the US population

期刊

INTERNATIONAL JOURNAL OF EATING DISORDERS
卷 45, 期 5, 页码 711-718

出版社

WILEY
DOI: 10.1002/eat.22006

关键词

anorexia nervosa; bulimia nervosa; EDNOS; EDNOS-subtypes; classification; DSM

资金

  1. NCS-A [Z08-MH002808, U01-MH60220]
  2. National Institute of Mental Health [R01 MH079979]
  3. Baker Foundation (Australia)
  4. Pfizer
  5. GlaxoSmithKline
  6. Ortho-McNeil
  7. Intramural Research Program

向作者/读者索取更多资源

Objective: To examine prevalence and clinical correlates of eating disorder not otherwise specified (EDNOS) in the US population. Method: Two cross-sectional surveys of adults and adolescents used the WHO CIDI to assess DSM-IV criteria for anorexia nervosa (AN), bulimia nervosa (BN), and EDNOS. Results: Lifetime prevalence of EDNOS was 4.78% in adolescents and 4.64% in adults. The majority of adolescents and adults with an eating disorder presented with EDNOS. Three-quarters of participants with EDNOS met criteria for comorbid disorders, while one-quarter endorsed suicidality. Severity correlates were equally prevalent in EDNOS and AN, whereas comparisons between EDNOS and BN varied by specific correlate and sample. Adolescents with subthreshold AN (SAN) endorsed more anxiety than AN (p < .05), and adolescents and adults with SAN endorsed more suicidal plans than AN (p's < .05). Discussion: Findings increase our understanding of the clinical relevance of EDNOS. Eating disorder diagnostic nomenclature requires modification to capture the full spectrum. (c) 2012 by Wiley Periodicals, Inc. Int J Eat Disord 2012.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据